Even With A 27% Surge, Cautious Investors Are Not Rewarding Shanghai Medicilon Inc.'s (SHSE:688202) Performance Completely

Simply Wall St20:53 ET

Shanghai Medicilon Inc. (688202.SH): Has cumulatively repurchased 0.1917% of the company's shares.

On August 2, Glonhooi reported that up to July 31, 2024, shanghai medicilon inc has repurchased 258,153 shares of the company through the Shanghai Stock Exchange trading system by centralized bidding, accounting for 0.1917% of the total share capital of the company. The highest and lowest repurchase prices were 32.55 yuan/share and 26.44 yuan/share, respectively, and the total amount paid was RMB 7,450,315.99 (excluding transaction costs such as stamp duty and brokerage fees).

Gelonghui FinanceAug 2 05:08 ET

Medicilon Y Hengrui Pharma Profundizan La Colaboración Estratégica

PR NewswireAug 2 04:30 ET

Medicilon Et Hengrui Pharma Renforcent Leur Collaboration Stratégique Pour Soutenir L'innovation Dans Les ADC, Les Petits Acides Nucléiques Et Les Médicaments CGT

PR NewswireAug 2 04:30 ET

Shanghai Medicilon (SHSE:688202) Has Debt But No Earnings; Should You Worry?

Simply Wall StJul 31 20:02 ET

Medicilon and Hengrui Pharma Deepen Strategic Collaboration to Support Innovation in ADCs, Small Nucleic Acids, and CGT Drugs

PR NewswireJul 31 10:39 ET